Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments

Por Terris‐Prestholt, Fern, Quaife, Matthew, Vickerman, Peter
Publicado no Health Econ (2016)

Opiate substitution treatment and HCV prevention: Building an evidence base?

Por Vickerman, Peter, Page, Kimberly, Maher, Lisa, Hickman, Matthew
Publicado no Addiction (2014)

The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention

Por Martin, Natasha K., Vickerman, Peter, Dore, Gregory, Hickman, Matthew
Publicado no Curr Opin HIV AIDS (2015)

Condoms and prevention of HIV: Are essential and effective, but additional methods are also needed

Por Foss, Anna M, Watts, Charlotte H, Vickerman, Peter, Heise, Lori
Publicado em 2004

Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England

Por Hope, Vivian, Kimber, Jo, Vickerman, Peter, Hickman, Matthew, Ncube, Fortune
Publicado em 2008

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database

Por Cornish, Rosie, Macleod, John, Strang, John, Vickerman, Peter, Hickman, Matt
Publicado em 2010

HIV transmission from drug injectors to partners who do not inject, and beyond: Modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia()

Por Mills, Harriet L., White, Edward, Colijn, Caroline, Vickerman, Peter, Heimer, Robert
Publicado em 2013

HCV Treatment as Prevention in People Who Inject Drugs – testing the evidence

Por Hickman, Matthew, De Angelis, Daniela, Vickerman, Peter, Hutchinson, Sharon, Martin, Natasha
Publicado no Curr Opin Infect Dis (2015)

The costs of HIV prevention for different target populations in Mumbai, Thane and Banglalore

Por Chandrashekar Sudha, Vassall Anna, Reddy Bhaskar, Shetty Govindraj, Vickerman Peter, Alary Michel
Publicado em 2011-12-01

Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users

Por Martin, Natasha K., Pitcher, Ashley B., Vickerman, Peter, Vassall, Anna, Hickman, Matthew
Publicado em 2011

The costs of HIV prevention for different target populations in Mumbai, Thane and Bangalore

Por Chandrashekar, Sudha, Vassall, Anna, Reddy, Bhaskar, Shetty, Govindraj, Vickerman, Peter, Alary, Michel
Publicado em 2011

Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data

Por Sacks-Davis, Rachel, McBryde, Emma, Grebely, Jason, Hellard, Margaret, Vickerman, Peter
Publicado no J R Soc Interface (2015)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitutio...

Por Martin, Natasha K., Hickman, Matthew, Hutchinson, Sharon J., Goldberg, David J., Vickerman, Peter
Publicado em 2013

Antiretroviral Therapy Uptake, Attrition, Adherence and Outcomes among HIV-Infected Female Sex Workers: A Systematic Review and Meta-Analysis

Por Mountain, Elisa, Mishra, Sharmistha, Vickerman, Peter, Pickles, Michael, Gilks, Charles, Boily, Marie-Claude
Publicado em 2014

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons

Por Martin, Natasha K, Hickman, Matthew, Miners, Alec, Hutchinson, Sharon J, Taylor, Avril, Vickerman, Peter
Publicado em 2013

How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa

Por Terris-Prestholt, Fern, Hanson, Kara, MacPhail, Catherine, Vickerman, Peter, Rees, Helen, Watts, Charlotte
Publicado em 2013

The Cost of Providing Combined Prevention and Treatment Services, Including ART, to Female Sex Workers in Burkina Faso

Por Cianci, Fiona, Sweeney, Sedona, Konate, Issouf, Nagot, Nicolas, Low, Andrea, Mayaud, Philippe, Vickerman, Peter
Publicado em 2014

Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa

Por Mumtaz, Ghina R., Weiss, Helen A., Vickerman, Peter, Larke, Natasha, Abu-Raddad, Laith J.
Publicado no AIDS (2015)

The Costs of Scaling Up HIV Prevention for High Risk Groups: Lessons Learned from the Avahan Programme in India

Por Chandrashekar, Sudhashree, Guinness, Lorna, Pickles, Michael, Shetty, Govindraj Y., Alary, Michel, Vickerman, Peter, Vassall, Anna
Publicado em 2014

The Impact of Syphilis Screening among Female Sex Workers in China: A Modelling Study

Por Mitchell, Kate M., Cox, Andrew P., Mabey, David, Tucker, Joseph D., Peeling, Rosanna W., Vickerman, Peter
Publicado em 2013